|
|
Thomson Financial Business Description:
| The Group's principal activity is to develop, manufacture and sell human therapeutics for life-threatening diseases. The Group includes three segments: Product sale which manufactures markets and sells pharmaceutical products for patients with cancer and other life-threatening diseases. Royalties, a source of revenue which is derived from sales of marketed products from PEG-INTRON, PEGASYS and MACUGEN that utilize our proprietary technology. Contract Manufacturing, where we utilize a portion of our excess manufacturing capacity to provide contract manufacturing services for a number of injectable products, such as single- and dual-chamber vial filling and lipid Complex formulations. The Group's products include ABELCET, ADAGEN, DEPOCYT and ONCASPAR. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on Enzon Pharmaceuticals Inc
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
